The appointment strengthens the board’s financial expertise, particularly relevant given Du’s biopharma CFO experience. Monitor Audit Committee activities and future financial reporting for signs of enhanced oversight.
Price Chart
Executive Summary
Emmaus Life Sciences appointed Henry H. Du to its Board of Directors and as a member of the Audit Committee, effective April 16, 2026, following the resignation of Jon Kuwahara. Du brings financial leadership experience from Alpha Cognition and other life sciences firms.
Key Facts
- Henry H. Du was appointed to the Board of Directors on April 16, 2026, filling the vacancy created by Jon Kuwahara's resignation.
- Mr. Du is expected to join the Audit Committee, replacing Mr. Kuwahara.
- Du serves as Vice President of Finance, Accounting, and interim CFO at Alpha Cognition, Inc. (NASDAQ: ACOG).
- He is a Certified Public Accountant with a BA from Claremont McKenna College.
- No family relationships exist between Du and other company officers or directors.
- Compensation for Du will be consistent with other directors; no related-party transactions disclosed.
Financial Impact
No immediate financial impact; standard director compensation expected.
Risk Factors
- Integration risk if Du’s dual roles at Alpha Cognition create time constraints.
- Board transition risk following Kuwahara’s departure, though orderly succession appears planned.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-045250 |
| Document: 0001213900-26-045250-index-headers.html | 0001213900-26-045250 |
| Document: 0001213900-26-045250-index.html | 0001213900-26-045250 |
| Document: 0001213900-26-045250.txt | 0001213900-26-045250 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 8-K | $0.0115 | awaiting T+60 | — | $0.0460 (+300.00%) |
Apr 17, 2026 27w ago | 8-K | $0.009100 $0.0115 | ▲ +25.93% | ▲ +19.16% | $0.0460 (+405.49%) |
Mar 31, 2026 29w ago | 8-K | $0.0150 $0.0100 | ▲ +33.33% | ▲ +45.72% | $0.0460 (−206.67%) |
Mar 4, 2026 33w ago | 8-K | $0.0145 $0.009600 | ▼ −33.79% | ▼ −45.09% | $0.0460 (+217.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers